Message Center
{{ messageCount }} Messages
Watched Genes
{{$index + 1}}. {{ watchedObject.symbol }} (RGD ID:{{watchedObject.rgdId}})
Watched Ontology Terms
{{$index + 1}}. {{ watchedTerm.term }} ({{watchedTerm.accId}})
{{gene.symbol}}: {{ gene.description }}
You must be logged in to use this feature
{{ loginError }}
Select categories you would like to watch. Updates to this gene will be sent to {{ username }}
x
Send Message
Gene: Exph5 (exophilin 5) Rattus norvegicus
Analyze
Symbol:
Exph5
Name:
exophilin 5
RGD ID:
1560308
Description:
Predicted to enable small GTPase binding activity. Predicted to be involved in keratinocyte development; multivesicular body sorting pathway; and positive regulation of secretion by cell. Predicted to be active in endosome. Human ortholog(s) of this gene implicated in epidermolysis bullosa simplex. Orthologous to human EXPH5 (exophilin 5); INTERACTS WITH 1-naphthyl isothiocyanate; 17beta-estradiol; 2,3,7,8-tetrachlorodibenzodioxine.
Type:
protein-coding
RefSeq Status:
VALIDATED
Previously known as:
exophilin-5; LOC315663; RGD1560308; similar to synaptotagmin-like homologue lacking C2 domains-b
RGD Orthologs
Alliance Orthologs
More Info
more info ...
More Info
Species
Gene symbol and name
Data Source
Assertion derived from
less info ...
Orthologs 1
Homo sapiens (human):
EXPH5 (exophilin 5) HGNC
EggNOG, Ensembl, HomoloGene, Inparanoid, NCBI, OMA, OrthoDB, OrthoMCL, Panther, Treefam
Mus musculus (house mouse):
Exph5 (exophilin 5) Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Chinchilla lanigera (long-tailed chinchilla):
Exph5 (exophilin 5) Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Pan paniscus (bonobo/pygmy chimpanzee):
EXPH5 (exophilin 5) Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Canis lupus familiaris (dog):
EXPH5 (exophilin 5) Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Ictidomys tridecemlineatus (thirteen-lined ground squirrel):
Exph5 (exophilin 5) Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Sus scrofa (pig):
LOC100512977 (KDEL motif-containing protein 2) Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Chlorocebus sabaeus (green monkey):
EXPH5 (exophilin 5) Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Heterocephalus glaber (naked mole-rat):
Exph5 (exophilin 5) Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Rattus rattus (black rat):
Exph5 (exophilin 5) Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Alliance orthologs 3
Mus musculus (house mouse):
Exph5 (exophilin 5)
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Homo sapiens (human):
EXPH5 (exophilin 5)
Alliance
DIOPT (Ensembl Compara|HGNC|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Xenopus tropicalis (tropical clawed frog):
exph5
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OrthoFinder|OrthoInspector|PANTHER|SonicParanoid)
Latest Assembly:
GRCr8 - GRCr8 Assembly
Position:
Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCr8 8 62,595,116 - 62,671,575 (+) NCBI GRCr8 GRCr8 GRCr8 GRCr8 Ensembl 8 62,595,116 - 62,671,575 (+) Ensembl GRCr8 mRatBN7.2 8 53,698,825 - 53,775,371 (+) NCBI mRatBN7.2 mRatBN7.2 mRatBN7.2 Ensembl 8 53,698,852 - 53,773,169 (+) Ensembl mRatBN7.2 Rnor_6.0 8 57,885,932 - 57,962,574 (+) NCBI Rnor_6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 8 57,886,168 - 57,962,708 (+) Ensembl rn6 Rnor6.0 Rnor_5.0 8 56,462,914 - 56,544,836 (+) NCBI Rnor_5.0 Rnor_5.0 rn5 RGSC_v3.4 8 56,762,507 - 56,835,516 (+) NCBI RGSC_v3.4 RGSC_v3.4 rn4 Celera 8 53,189,832 - 53,266,110 (+) NCBI Celera Cytogenetic Map 8 q24 NCBI
JBrowse:
Imported Disease Annotations - ClinVar
Imported Disease Annotations - CTD
Imported Disease Annotations - OMIM
Only show annotations with direct experimental evidence (0 objects hidden)
Exph5 Rat (-)-epigallocatechin 3-gallate multiple interactions ISO EXPH5 (Homo sapiens) 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of EXPH5 mRNA CTD PMID:22079256 Exph5 Rat (1->4)-beta-D-glucan multiple interactions ISO Exph5 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of EXPH5 mRNA CTD PMID:36331819 Exph5 Rat 1,1-dichloroethene decreases expression ISO Exph5 (Mus musculus) 6480464 vinylidene chloride results in decreased expression of EXPH5 mRNA CTD PMID:26682919 Exph5 Rat 1-naphthyl isothiocyanate decreases expression EXP 6480464 1-Naphthylisothiocyanate results in decreased expression of EXPH5 mRNA CTD PMID:30723492 Exph5 Rat 17beta-estradiol increases expression EXP 6480464 Estradiol results in increased expression of EXPH5 mRNA CTD PMID:35192832 Exph5 Rat 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO Exph5 (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in increased expression of EXPH5 mRNA CTD PMID:19933214 Exph5 Rat 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of EXPH5 mRNA CTD PMID:33387578 Exph5 Rat 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO Exph5 (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in decreased expression of EXPH5 mRNA CTD PMID:25975270|PMID:26290441 Exph5 Rat 2-hydroxypropanoic acid decreases expression ISO EXPH5 (Homo sapiens) 6480464 Lactic Acid results in decreased expression of EXPH5 mRNA CTD PMID:30851411 Exph5 Rat 3,3',4,4',5-pentachlorobiphenyl increases expression ISO EXPH5 (Homo sapiens) 6480464 3,4,5,3',4'-pentachlorobiphenyl results in increased expression of EXPH5 mRNA CTD PMID:19692669 Exph5 Rat 4,4'-diaminodiphenylmethane increases expression ISO Exph5 (Mus musculus) 6480464 4,4'-diaminodiphenylmethane results in increased expression of EXPH5 mRNA CTD PMID:18648102 Exph5 Rat 4,4'-sulfonyldiphenol increases expression ISO Exph5 (Mus musculus) 6480464 bisphenol S results in increased expression of EXPH5 mRNA CTD PMID:30951980|PMID:39298647 Exph5 Rat 4,4'-sulfonyldiphenol decreases methylation ISO EXPH5 (Homo sapiens) 6480464 bisphenol S results in decreased methylation of EXPH5 gene CTD PMID:31601247 Exph5 Rat 4-hydroxyphenyl retinamide increases expression ISO Exph5 (Mus musculus) 6480464 Fenretinide results in increased expression of EXPH5 mRNA CTD PMID:28973697 Exph5 Rat aflatoxin B1 decreases expression ISO EXPH5 (Homo sapiens) 6480464 Aflatoxin B1 results in decreased expression of EXPH5 mRNA CTD PMID:27153756 Exph5 Rat all-trans-retinoic acid increases expression ISO EXPH5 (Homo sapiens) 6480464 Tretinoin results in increased expression of EXPH5 mRNA CTD PMID:21934132 Exph5 Rat all-trans-retinoic acid decreases expression ISO EXPH5 (Homo sapiens) 6480464 Tretinoin results in decreased expression of EXPH5 mRNA CTD PMID:33167477 Exph5 Rat antirheumatic drug increases expression ISO EXPH5 (Homo sapiens) 6480464 Antirheumatic Agents results in increased expression of EXPH5 mRNA CTD PMID:24449571 Exph5 Rat arsane multiple interactions ISO EXPH5 (Homo sapiens) 6480464 [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of EXPH5 more ... CTD PMID:39836092 Exph5 Rat arsenic atom multiple interactions ISO EXPH5 (Homo sapiens) 6480464 [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of EXPH5 more ... CTD PMID:39836092 Exph5 Rat benzo[a]pyrene affects methylation ISO EXPH5 (Homo sapiens) 6480464 Benzo(a)pyrene affects the methylation of EXPH5 promoter CTD PMID:27901495 Exph5 Rat benzo[a]pyrene diol epoxide I affects expression ISO EXPH5 (Homo sapiens) 6480464 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide affects the expression of EXPH5 mRNA CTD PMID:20382639 Exph5 Rat benzo[a]pyrene diol epoxide I decreases expression ISO EXPH5 (Homo sapiens) 6480464 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of EXPH5 mRNA CTD PMID:20018196 Exph5 Rat bis(2-ethylhexyl) phthalate increases expression ISO EXPH5 (Homo sapiens) 6480464 Diethylhexyl Phthalate results in increased expression of EXPH5 mRNA CTD PMID:31163220 Exph5 Rat bis(2-ethylhexyl) phthalate increases expression ISO Exph5 (Mus musculus) 6480464 Diethylhexyl Phthalate results in increased expression of EXPH5 mRNA CTD PMID:34319233 Exph5 Rat bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of EXPH5 mRNA CTD PMID:25181051 Exph5 Rat bisphenol A decreases methylation ISO EXPH5 (Homo sapiens) 6480464 bisphenol A results in decreased methylation of EXPH5 gene CTD PMID:31601247 Exph5 Rat bisphenol A increases expression ISO Exph5 (Mus musculus) 6480464 bisphenol A results in increased expression of EXPH5 mRNA CTD PMID:30951980|PMID:32156529|PMID:32365465|PMID:34585602 Exph5 Rat bisphenol F increases expression ISO Exph5 (Mus musculus) 6480464 bisphenol F results in increased expression of EXPH5 mRNA CTD PMID:30951980|PMID:38685157 Exph5 Rat butanal increases expression ISO EXPH5 (Homo sapiens) 6480464 butyraldehyde results in increased expression of EXPH5 mRNA CTD PMID:26079696 Exph5 Rat C60 fullerene decreases expression EXP 6480464 fullerene C60 results in decreased expression of EXPH5 mRNA CTD PMID:19167457 Exph5 Rat cadmium atom decreases expression ISO Exph5 (Mus musculus) 6480464 Cadmium results in decreased expression of EXPH5 mRNA CTD PMID:24067728 Exph5 Rat cadmium atom multiple interactions ISO Exph5 (Mus musculus) 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of EXPH5 more ... CTD PMID:37236586 Exph5 Rat cadmium dichloride multiple interactions ISO Exph5 (Mus musculus) 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of EXPH5 more ... CTD PMID:37236586 Exph5 Rat CGP 52608 multiple interactions ISO EXPH5 (Homo sapiens) 6480464 CGP 52608 promotes the reaction [RORA protein binds to EXPH5 gene] CTD PMID:28238834 Exph5 Rat chlorpyrifos decreases expression ISO Exph5 (Mus musculus) 6480464 Chlorpyrifos results in decreased expression of EXPH5 mRNA CTD PMID:37019170 Exph5 Rat choline multiple interactions ISO Exph5 (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression more ... CTD PMID:20938992 Exph5 Rat chromium(6+) affects expression ISO EXPH5 (Homo sapiens) 6480464 chromium hexavalent ion affects the expression of EXPH5 mRNA CTD PMID:30690063 Exph5 Rat cisplatin decreases expression ISO EXPH5 (Homo sapiens) 6480464 Cisplatin results in decreased expression of EXPH5 mRNA CTD PMID:27392435 Exph5 Rat cyclosporin A increases expression ISO EXPH5 (Homo sapiens) 6480464 Cyclosporine results in increased expression of EXPH5 mRNA CTD PMID:20106945 Exph5 Rat cyclosporin A decreases expression ISO EXPH5 (Homo sapiens) 6480464 Cyclosporine results in decreased expression of EXPH5 mRNA CTD PMID:27989131 Exph5 Rat dimethylarsinic acid multiple interactions ISO Exph5 (Mus musculus) 6480464 [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results more ... CTD PMID:34876320 Exph5 Rat dioxygen multiple interactions ISO Exph5 (Mus musculus) 6480464 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of EXPH5 mRNA CTD PMID:30529165 Exph5 Rat dorsomorphin multiple interactions ISO EXPH5 (Homo sapiens) 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased more ... CTD PMID:27188386 Exph5 Rat enniatin increases expression ISO EXPH5 (Homo sapiens) 6480464 enniatins results in increased expression of EXPH5 mRNA CTD PMID:36016515 Exph5 Rat entinostat increases expression ISO EXPH5 (Homo sapiens) 6480464 entinostat results in increased expression of EXPH5 mRNA CTD PMID:27188386 Exph5 Rat folic acid multiple interactions ISO Exph5 (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression more ... CTD PMID:20938992 Exph5 Rat fulvestrant decreases methylation ISO EXPH5 (Homo sapiens) 6480464 Fulvestrant results in decreased methylation of EXPH5 gene CTD PMID:31601247 Exph5 Rat gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of EXPH5 mRNA CTD PMID:33387578 Exph5 Rat GSK-J4 increases expression ISO EXPH5 (Homo sapiens) 6480464 GSK-J4 results in increased expression of EXPH5 mRNA CTD PMID:29301935 Exph5 Rat inulin multiple interactions ISO Exph5 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of EXPH5 mRNA CTD PMID:36331819 Exph5 Rat L-methionine multiple interactions ISO Exph5 (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression more ... CTD PMID:20938992 Exph5 Rat methylarsonic acid multiple interactions ISO Exph5 (Mus musculus) 6480464 [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results more ... CTD PMID:34876320 Exph5 Rat nickel sulfate decreases expression ISO EXPH5 (Homo sapiens) 6480464 nickel sulfate results in decreased expression of EXPH5 mRNA CTD PMID:22714537 Exph5 Rat paracetamol increases expression ISO EXPH5 (Homo sapiens) 6480464 Acetaminophen results in increased expression of EXPH5 mRNA CTD PMID:26690555 Exph5 Rat paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of EXPH5 mRNA CTD PMID:33387578 Exph5 Rat paraquat decreases expression EXP 6480464 Paraquat results in decreased expression of EXPH5 mRNA CTD PMID:32680482 Exph5 Rat pentanal increases expression ISO EXPH5 (Homo sapiens) 6480464 pentanal results in increased expression of EXPH5 mRNA CTD PMID:26079696 Exph5 Rat perfluorooctane-1-sulfonic acid multiple interactions ISO Exph5 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of EXPH5 mRNA; [perfluorooctane sulfonic more ... CTD PMID:36331819 Exph5 Rat phenylmercury acetate increases expression ISO EXPH5 (Homo sapiens) 6480464 Phenylmercuric Acetate results in increased expression of EXPH5 mRNA CTD PMID:26272509 Exph5 Rat phenylmercury acetate multiple interactions ISO EXPH5 (Homo sapiens) 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased more ... CTD PMID:27188386 Exph5 Rat potassium chromate decreases expression ISO EXPH5 (Homo sapiens) 6480464 potassium chromate(VI) results in decreased expression of EXPH5 mRNA CTD PMID:22079256 Exph5 Rat potassium chromate increases expression ISO EXPH5 (Homo sapiens) 6480464 potassium chromate(VI) results in increased expression of EXPH5 mRNA CTD PMID:22714537 Exph5 Rat potassium chromate multiple interactions ISO EXPH5 (Homo sapiens) 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of EXPH5 mRNA CTD PMID:22079256 Exph5 Rat pregnenolone 16alpha-carbonitrile decreases expression ISO Exph5 (Mus musculus) 6480464 Pregnenolone Carbonitrile results in decreased expression of EXPH5 mRNA CTD PMID:28903501 Exph5 Rat propanal increases expression ISO EXPH5 (Homo sapiens) 6480464 propionaldehyde results in increased expression of EXPH5 mRNA CTD PMID:26079696 Exph5 Rat rac-lactic acid decreases expression ISO EXPH5 (Homo sapiens) 6480464 Lactic Acid results in decreased expression of EXPH5 mRNA CTD PMID:30851411 Exph5 Rat SB 431542 multiple interactions ISO EXPH5 (Homo sapiens) 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased more ... CTD PMID:27188386 Exph5 Rat silicon dioxide decreases expression ISO EXPH5 (Homo sapiens) 6480464 Silicon Dioxide analog results in decreased expression of EXPH5 mRNA CTD PMID:25895662 Exph5 Rat silicon dioxide decreases expression ISO Exph5 (Mus musculus) 6480464 Silicon Dioxide results in decreased expression of EXPH5 mRNA CTD PMID:23221170 Exph5 Rat sodium arsenate multiple interactions ISO Exph5 (Mus musculus) 6480464 [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results more ... CTD PMID:34876320 Exph5 Rat sodium arsenite decreases expression ISO EXPH5 (Homo sapiens) 6480464 sodium arsenite results in decreased expression of EXPH5 mRNA CTD PMID:22714537|PMID:34032870 Exph5 Rat sodium arsenite decreases expression ISO Exph5 (Mus musculus) 6480464 sodium arsenite results in decreased expression of EXPH5 mRNA CTD PMID:37682722 Exph5 Rat sodium arsenite multiple interactions ISO Exph5 (Mus musculus) 6480464 [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results more ... CTD PMID:34876320 Exph5 Rat sodium arsenite multiple interactions ISO EXPH5 (Homo sapiens) 6480464 [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of EXPH5 more ... CTD PMID:39836092 Exph5 Rat sotorasib multiple interactions ISO EXPH5 (Homo sapiens) 6480464 [sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of EXPH5 mRNA CTD PMID:36139627 Exph5 Rat tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of EXPH5 mRNA CTD PMID:31150632 Exph5 Rat tetrachloromethane decreases expression ISO Exph5 (Mus musculus) 6480464 Carbon Tetrachloride results in decreased expression of EXPH5 mRNA CTD PMID:31919559 Exph5 Rat trametinib multiple interactions ISO EXPH5 (Homo sapiens) 6480464 [sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of EXPH5 mRNA CTD PMID:36139627 Exph5 Rat trichloroethene increases expression EXP 6480464 Trichloroethylene results in increased expression of EXPH5 mRNA CTD PMID:33387578 Exph5 Rat trichostatin A increases expression ISO EXPH5 (Homo sapiens) 6480464 trichostatin A results in increased expression of EXPH5 mRNA CTD PMID:24935251|PMID:26705709 Exph5 Rat triclosan decreases expression ISO EXPH5 (Homo sapiens) 6480464 Triclosan results in decreased expression of EXPH5 mRNA CTD PMID:30510588 Exph5 Rat triphenyl phosphate affects expression EXP 6480464 triphenyl phosphate affects the expression of EXPH5 mRNA CTD PMID:30589522 Exph5 Rat triphenyl phosphate affects expression ISO EXPH5 (Homo sapiens) 6480464 triphenyl phosphate affects the expression of EXPH5 mRNA CTD PMID:37042841 Exph5 Rat triptonide increases expression ISO Exph5 (Mus musculus) 6480464 triptonide results in increased expression of EXPH5 mRNA CTD PMID:33045310 Exph5 Rat valproic acid decreases expression ISO EXPH5 (Homo sapiens) 6480464 Valproic Acid results in decreased expression of EXPH5 mRNA CTD PMID:29154799 Exph5 Rat valproic acid decreases expression EXP 6480464 Valproic Acid results in decreased expression of EXPH5 mRNA CTD PMID:29427782 Exph5 Rat valproic acid affects expression ISO EXPH5 (Homo sapiens) 6480464 Valproic Acid affects the expression of EXPH5 mRNA CTD PMID:25979313 Exph5 Rat valproic acid increases expression ISO EXPH5 (Homo sapiens) 6480464 Valproic Acid results in increased expression of EXPH5 mRNA CTD PMID:23179753|PMID:24383497|PMID:24935251|PMID:26272509|PMID:27188386 Exph5 Rat valproic acid multiple interactions ISO EXPH5 (Homo sapiens) 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased more ... CTD PMID:27188386 Exph5 Rat vorinostat increases expression ISO EXPH5 (Homo sapiens) 6480464 vorinostat results in increased expression of EXPH5 mRNA CTD PMID:27188386
QTLs in Region (GRCr8)
2313057 Bss76 Bone structure and strength QTL 76 3 0.0001 tibia size trait (VT:0100001) tibia midshaft cross-sectional area (CMO:0001717) 8 39106258 91341052 Rat 1298065 Scl16 Serum cholesterol level QTL 16 3.8 blood cholesterol amount (VT:0000180) plasma total cholesterol level (CMO:0000585) 8 39752803 84752803 Rat 1549908 Neudeg1 Neurodegradation QTL 1 5.5 0 nervous system integrity trait (VT:0010566) logarithm of the ratio of the lesioned side motor neuron count to contralateral side motor neuron count (CMO:0001986) 8 58337123 103337123 Rat 1554321 Bmd3 Bone mineral density QTL 3 7.9 0.0001 femur mineral mass (VT:0010011) volumetric bone mineral density (CMO:0001553) 8 49849908 118871671 Rat 2313067 Bss77 Bone structure and strength QTL 77 3.1 0.0001 tibia size trait (VT:0100001) tibia midshaft endosteal cross-sectional area (CMO:0001716) 8 39106258 91341052 Rat 1578769 Uae31 Urinary albumin excretion QTL 31 3.3 0.001 urine albumin amount (VT:0002871) urine albumin excretion rate (CMO:0000757) 8 39106363 103375781 Rat 1298079 Activ2 Activity QTL 2 9.5 0.000001 voluntary movement trait (VT:0003491) rearing measurement (CMO:0001515) 8 50763951 95763951 Rat 11556286 Cm81 Cardiac mass QTL 81 0.01 heart mass (VT:0007028) heart weight to body weight ratio (CMO:0000074) 8 39106258 84106258 Rat 70161 Bp62 Blood pressure QTL 62 2.9 0.001 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 8 51589699 99045312 Rat 1358912 Bw51 Body weight QTL 51 2.95 body mass (VT:0001259) body weight (CMO:0000012) 8 60248093 105248093 Rat 1578765 Klgr1 Kidney lesion grade QTL 1 3.3 0.0001 kidney morphology trait (VT:0002135) organ lesion measurement (CMO:0000677) 8 39106363 103375781 Rat 61464 Niddm11 Non-insulin dependent diabetes mellitus QTL 11 3.1 0.001 blood insulin amount (VT:0001560) plasma insulin level (CMO:0000342) 8 44477926 89477926 Rat 4889938 Bss89 Bone structure and strength QTL 89 3.8 tibia size trait (VT:0100001) tibia cortical bone volume (CMO:0001725) 8 58991697 91341052 Rat 1578755 Pur5 Proteinuria QTL 5 3.3 0.0001 urine total protein amount (VT:0000032) urine total protein excretion rate (CMO:0000756) 8 39106258 103375958 Rat 2313086 Bss60 Bone structure and strength QTL 60 4.1 0.0001 tibia length (VT:0004357) tibia length (CMO:0000450) 8 58991697 91341052 Rat 2313088 Bss75 Bone structure and strength QTL 75 3.1 0.0001 body length (VT:0001256) body length, nose to rump (CMO:0000079) 8 39106258 91341052 Rat 631210 Bw3 Body weight QTL3 5.9 mesenteric fat pad mass (VT:0010427) mesenteric fat pad weight to body weight ratio (CMO:0000654) 8 61019838 121662124 Rat 1358896 Bp262 Blood pressure QTL 262 2.89 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 8 35464071 107982864 Rat 731182 Uae24 Urinary albumin excretion QTL 24 6.4 urine albumin amount (VT:0002871) urine albumin excretion rate (CMO:0000757) 8 47541419 92541419 Rat 631648 Stl5 Serum triglyceride level QTL 5 4 0.0003 blood triglyceride amount (VT:0002644) plasma triglyceride level (CMO:0000548) 8 35464071 71842899 Rat 61353 Bp35 Blood pressure QTL 35 0.001 arterial blood pressure trait (VT:2000000) diastolic blood pressure (CMO:0000005) 8 39106258 84106258 Rat 1331837 Bw23 Body weight QTL 23 4.19 0.00007 body mass (VT:0001259) body weight (CMO:0000012) 8 55428416 107963099 Rat 631842 Inf1 Infertility severity QTL 1 4.1 0.001 seminal gland mass (VT:0010524) seminal vesicle wet weight (CMO:0001603) 8 31543661 76543661 Rat 737824 Hcar10 Hepatocarcinoma resistance QTL 10 2.9 liver integrity trait (VT:0010547) liver tumorous lesion number (CMO:0001068) 8 49610204 68373388 Rat 1359033 Bp273 Blood pressure QTL 273 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 8 39106258 84106258 Rat 1331769 Rf39 Renal function QTL 39 3.871 urine output (VT:0003620) timed urine volume (CMO:0000260) 8 50763951 107970527 Rat 61358 Bp39 Blood pressure QTL 39 2 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 8 44447837 89447837 Rat 1358906 Bp253 Blood pressure QTL 253 4 0.0004 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 8 49610204 94610204 Rat 1358907 Cm40 Cardiac mass QTL 40 1.89 heart mass (VT:0007028) heart weight to body weight ratio (CMO:0000074) 8 35464071 107982864 Rat 1331744 Bp217 Blood pressure QTL 217 3.398 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 8 39106258 67378345 Rat 70197 BpQTLcluster8 Blood pressure QTL cluster 8 3.482 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 8 55428333 127966348 Rat 2313046 Bss78 Bone structure and strength QTL 78 3.5 0.0001 tibia strength trait (VT:1000284) tibia total energy absorbed before break (CMO:0001736) 8 39106258 91341052 Rat 2316950 Scl66 Serum cholesterol level QTL 66 4.1 blood cholesterol amount (VT:0000180) plasma total cholesterol level (CMO:0000585) 8 39106363 114525825 Rat 1582254 Kidm31 Kidney mass QTL 31 3 kidney mass (VT:0002707) both kidneys wet weight (CMO:0000085) 8 49245178 94245178 Rat 724540 Uae8 Urinary albumin excretion QTL 8 5 urine albumin amount (VT:0002871) urine albumin level (CMO:0000130) 8 39106258 103375958 Rat 1358892 Kidm26 Kidney mass QTL 26 3.69 kidney mass (VT:0002707) both kidneys wet weight to body weight ratio (CMO:0000340) 8 35464071 107982864 Rat 631216 Stl9 Serum triglyceride level QTL 9 4.71 0.0001 blood triglyceride amount (VT:0002644) serum triglyceride level (CMO:0000360) 8 50763951 67219641 Rat 1582243 Bw66 Body weight QTL 66 3.4 0.0048 body mass (VT:0001259) body weight (CMO:0000012) 8 49245178 94245178 Rat 5684973 Bss100 Bone structure and strength QTL 100 4.7 tibia area (VT:1000281) tibia area measurement (CMO:0001382) 8 58991697 91341052 Rat 61373 Mcs4 Mammary carcinoma susceptibility QTL 4 1.1 mammary gland integrity trait (VT:0010552) mammary tumor number (CMO:0000343) 8 44475043 89475043 Rat
